Gritstone Oncology, Inc. Skyrocketed
Gritstone Oncology, Inc. (GRTS:NASDAQ) rocketted at $13.2, representing a gain of 25.7%. On Mon, Nov 29, 2021, GRTS:NASDAQ touched a New 2-Week Intraday High of $11.4. The stock got featured on our News Catalysts scanner on Mon, Nov 29, 2021 at 07:49 AM in the 'BIOTECH' category. From Mon, Nov 15, 2021, the stock recorded 55.56% Up Days and 50.00% Green Days
The stock spiked on Fri, Sep 17, 2021 at $14.36 with a volume of 5M+, and its share price has been moving sideways in recent weeks.
About Gritstone Oncology, Inc. (GRTS:NASDAQ)
Gritstone Oncology Inc is a United States based immune-oncology company. The company is engaged in developing personalized cancer immunotherapies to fight multiple cancer types. It is building a pipeline of Immunotherapies product candidates for patients with solid tumors including GRANITE-001 and SLATE-001.
Top 10 Gainers:
- Cumberland Pharmaceuticals Inc. (CPIX:NASDAQ), 128.64%
- iFresh Inc. (IFMK:NASDAQ), 50%
- VOSO (VOSO:NASDAQ), 43.95%
- MEI Pharma, Inc. (MEIP:NASDAQ), 37.55%
- Pioneer Power Solutions, Inc. (PPSI:NASDAQ), 32.5%
- Ardelyx, Inc. (ARDX:NASDAQ), 32.24%
- ImmunoGen, Inc. (IMGN:NASDAQ), 29.89%
- Gritstone Oncology, Inc. (GRTS:NASDAQ), 25.71%
- CLNN (CLNN:NASDAQ), 22.37%
- GBS (GBS:NASDAQ), 22.22%